Completed NA INTERVENTIONAL 2-arm NCT01197859

Three Month Clinical Evaluation of the Contamac 74% Silicone Hydrogel Contact Lens

Sponsor: Contamac Ltd

Interventions Biofinity Definitive Contact Lens

Updated 8 times since 2017 Last updated: Aug 10, 2020 Started: Aug 31, 2008 Primary completion: Feb 28, 2009 Completion: Feb 28, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Vision Correction, this trial is completed. The trial is conducted by Contamac Ltd and has accumulated 8 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Sep 2020 — Jan 2021 [monthly]

Completed NA

Status: Withheld → Completed · Phase: None → NA
Jun 2018 — Sep 2020 [monthly]

Withheld

▶ Show 3 earlier versions

Apr 2018 — Jun 2018 [monthly]

Withheld

Phase: NA → None
Feb 2017 — Apr 2018 [monthly]

Withheld NA
Jan 2017 — Feb 2017 [monthly]

Withheld NA

First recorded

Aug 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Contamac Ltd

Data source: Contamac Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Farnham, United Kingdom